ADVANCED SOLID TUMOR MALIGNANCY
Clinical trials for ADVANCED SOLID TUMOR MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody KBA1412 tested in patients with Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new drug called KBA1412, a lab-made antibody that targets a protein on cancer cells. It was given alone or with another cancer drug (pembrolizumab) to 16 adults with advanced solid tumors that had stopped responding to standard treatments. The main…
Matched conditions: ADVANCED SOLID TUMOR MALIGNANCY
Phase: PHASE1 • Sponsor: Kling Biotherapeutics B.V. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New injection targets tumors directly in advanced cancer trial
Disease control CompletedThis early-phase trial tested an experimental drug called CyPep-1, injected directly into tumors, either alone or with the immunotherapy pembrolizumab. The study included 60 adults with advanced solid cancers that had stopped responding to standard treatments. The main goals were…
Matched conditions: ADVANCED SOLID TUMOR MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated May 15, 2026 11:54 UTC